Low levels of serum asymmetric antibodies as a marker of threatened pregnancy

Journal of Reproductive Immunology

Volumn 79, Issue 2, 2009, Pages 201-210

  Barrientos, G ^a   Fuchs, D ^b   Schrocksnadel K ^b   Ruecke, M ^a   Garcia, M G ^a   Klapp, B F ^a   Raghupathy, R ^c   Miranda, S ^d   Arck, P C ^a   Blois, S M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c KUWAIT UNIVERSITY   (Kuwait)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Asymmetric antibodies; Indoleamine 2,3 dioxygenase; Pregnancy outcome

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADULT; ANTIBODIES; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; PREGNANCY; PREGNANCY OUTCOME;

EID: 61849104913     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2008.11.002     Document Type: Article

References (59)

1. Aluvihare V.R., Kallikourdis M., and Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5 (2004) 266-271
2. Arck P.C., Rücke M., Rose M., Szekeres-Bartho J., Douglas A.J., Pritsch M., Blois S.M., Pincus M.K., Bärenstrauch N., Dudenhausen J.W., Nakamura K., Sheps S., and Klapp B.F. Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod. Biomed. Online 17 1 (2008) 101-113
3. Baban B., Chandler P., McCool D., Marshall B., Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod. Immunol. 61 2 (2004) 67-77
4. Blois S., Tometten M., Kandil J., Hagen E., Klapp B.F., Margni R.A., and Arck P.C. Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies. J. Immunol. 174 4 (2005) 1820-1829
5. Byrne G.I., Lehmann L.K., Kirschbaum J.G., Borden E.C., Lee C.M., and Brown R.R. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J. Interferon Res. 6 4 (1986) 389-396
6. Canellada A., Blois S., Gentile T., and Margni R.A. In vitro modulation of protective antibody responses by estrogen, progesterone and interleukin-6. Am. J. Reprod. Immunol. 48 5 (2002) 334-343
7. Canellada A., Farber A., Zenclussen A.C., Gentile T., Dokmetjian J., Keil A., Blois S., Miranda S., Berod L., Gutierrez G., et al. Interleukin regulation of asymmetric antibody synthesized by isolated placental B cells. Am. J. Reprod. Immunol. 48 4 (2002) 275-282
8. Carbonetto C., Malchiodi E., and Margni R.A. IgG antibody type in sera from patients with chronic Chagas' disease. Inmunología (Barcelona) 5 (1986) 18-22
9. Chaouat G., Menu E., Clark D.A., Minkowsky M., Dy M., and Wegmann T.G. Control of fetal survival in CBA×DBA/2 mice by lymphokine therapy. J. Reprod. Fertil. 89 (1990) 447-458
10. Chaouat, G., Menu, E., Wegmann, T.G., 1991. Role of lymphokines of the CSF family and of TNF, gamma-interferon and IL-2 on placental growth and foetal survival studied in 2 murine models of spontaneous resorptions. In: Chaouat, G., Mowbry, G. (Eds.), Cellular and Molecular Biology of the Materno-Fetal Relationship, vol. 212. Colloque INSERM John Libbey Eurotext Ltd, Paris, London, pp. 91-100.
11. Chaouat G., Assal Meliani A., Martal J., Raghupathy R., Elliott J.F., Mosmann T., and Wegmann T.G. IL-10 prevents naturally occurring fetal loss in the CBA×DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J. Immunol. 154 9 (1995) 4261-4268
12. Clark D.A., Coulam C.B., Daya S., and Chaouat G. Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum. Reprod. Update 7 5 (2001) 501-511
13. Cordal M.E., and Margni R.A. Isolation, purification and biological properties of horse precipitating and non-precipitating antibodies. Immunochemistry 11 12 (1974) 765-770
14. Coulam C.B., and Clark D.A. Immunotherapy for recurrent abortion. Am. J. Reprod. Immunol. 32 (1994) 257-260
15. Eblen A.C., Gercel-Taylor C., Shields L.B., Sanfilippo J.S., Nakajima S.T., and Taylor D.D. Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil. Steril. 73 2 (2000) 305-313
16. Faust Z., Laskarin G., Rukavina D., and Szekeres-Bartho J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am. J. Reprod. Immunol. 42 (1999) 71-75
17. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., and Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196 (2002) 459-468
18. Fuchs D., Moller A.A., Reibnegger G., Werner E.R., Werner-Felmayer G., Dierich M.P., and Wachter H. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol. Lett. 28 3 (1991) 207-211
19. Fuchs, D., Möller, A.A., Weiss, G., Dierich, M.P., Wachter, H., 1993. Immune activation, impaired tryptophan metabolism and neurologic/psychiatric symptoms in HIV infection. In: Weis, S., Hippius, H. (Eds.), HIV Infection of the Central Nervous System. Hagrefe & Huber Publishers, Seattle, Washington, pp. 103-119.
20. Gentile T., Borel I.M., Angelucci J., Miranda S., and Margni R.A. Preferential synthesis of asymmetric antibodies in rats immunized with paternal particulate antigens: effect on pregnancy. J. Reprod. Immunol. 22 2 (1992) 173-183
21. Jablonowska B., Palfi M., Ernerudh J., Kjellberg S., and Selbing A. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment. Am. J. Reprod. Immunol. 45 4 (2001) 226-231
22. Kamimura S., Eguchi K., Yonezawa M., and Sekiba K. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med. Okayama 45 3 (1991) 135-139
23. Kelemen K., Bognar I., Paal M., and Szekeres-Bartho J. A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol. 167 1 (1996) 129-134
24. Kobayashi R.H., Hyman C.J., and Stiehm E.R. Immunologic maturation in an infant born to a mother with agammaglobulinemia. Am. J. Dis. Child 134 10 (1980) 942-944
25. Ledee-Bataille N., Lapree-Delage G., Taupin J.L., Dubanchet S., Frydman R., and Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum. Reprod. 17 1 (2002) 213-218
26. Leoni J., Labeta M., and Margni R.A. The asymmetric IgG non-precipitating antibody. Localization of the oligosaccharide involved, by concanavalin A interaction. Mol. Immunol. 23 12 (1986) 1397-1400
27. Makhseed, M., Raghupathy, R., Azizieh, F., Al-Shamali, E., Ashkanani, L., 2001. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Human Reprod. 16, 2219-2226.
28. Malan Borel I., Gentile T., Angelucci J., Margni R.A., and Binaghi R.A. Asymmetrically glycosylation IgG isolated from non-immune human sera. Biochem. Biophys. Acta 990 (1989) 162-164
29. Malan Borel I., Gentile T., Angelucci J., Pividori J., Guala M.C., Binaghi R.A., and Margni R.A. IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J. Reprod. Immunol. 20 2 (1991) 129-140
30. Margni R.A., and Binaghi R. Purification and properties of non-precipitating rabbit antibodies. Immunology 22 4 (1972) 557-563
31. Margni R.A., and Binaghi R.A. Nonprecipitating asymmetric antibodies. Annu. Rev. Immunol. 6 (1988) 535-554
32. Margni R.A., and Hajos S. Biological and physicochemical properties of purified anti-DNP guinea-pig non-precipitating antibodies. Immunology 24 3 (1973) 435-443
33. Margni R.A., and Malan Borel I. Paradoxical behavior of asymmetric IgG antibodies. Immunol. Rev. 163 (1998) 77-87
34. Margni R.A., Paz C.B., and Cordal M.E. Immunochemical behavior of sheep non-precipitating antibodies isolated by immunoadsorption. Immunochemistry 13 3 (1976) 209-214
35. Mellor A.L., and Munn D.H. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J. Reprod. Immunol. 52 1-2 (2001) 5-13
36. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2 9 (2002) 656-663
37. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., and Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 5380 (1998) 1191-1193
38. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., and Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189 (1999) 1363-1372
39. Nagaeva O., Jonsson L., and Mincheva-Nilsson L. Dominant IL-10 and TGF-β mRNA expression in γδT cells of human early pregnancy decidua suggests immunoregulatory potential. Am. J. Reprod. Immunol. 48 (2002) 9-17
40. Palfi M., Jablonowska B., Matthiesen L., and Ernerudh J. Circulating interferon-gamma- and interleukin-4-secreting cells in recurrent spontaneous abortions. Am. J. Reprod. Immunol. 41 4 (1999) 257-263
41. Piccinni M.P., Beloni L., Livi C., Maggi E., Scarselli G., and Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 4 9 (1998) 1020-1024
42. Porter T.F., and Scott J.R. Evidence-based care of recurrent miscarriage. Best Pract. Res. Clin. Obstet. Gynaecol. 19 1 (2005) 85-101
43. Prasad N.K.A., Papoff G., Zeuner A., Bonnin E., Kazatchkine M.D., Ruberti G., and Kaveri S.V. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J. Immunol. 161 (1998) 3781-3790
44. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin. Immunol. 13 (2001) 219-227
45. Raghupathy R., Makhseed M., Azizieh F., Omu A., Gupta M., and Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum. Reprod. 15 3 (2000) 713-718
46. Rigal D., Vermot-Desroches C., Heitz S., Bernaud J., Alfonsi F., and Monier J.C. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules. Clin. Immunol. Immunopathol. 71 (1994) 309-314
47. Rodger J.C. Lack of a requirement for a maternal humoral immune response to establish or maintain successful allogeneic pregnancy. Transplantation 40 4 (1985) 372-375
48. Ruiz J.E., Kwak J.Y.H., Baum L., Gilman-Sachs A., Beaman K.D., Kim Y.B., and Beer A.E. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 35 (1996) 370-375
49. Schröcksnadel H., Baier-Bitterlich G., Dapunt O., Wachter H., and Fuchs D. Decreased plasma tryptophan in pregnancy. Obstet. Gynecol. 88 1 (1996) 47-50
50. Stricker R.B., Steinleitner A., and Winger E.E. Intravenous immunoglobulin therapy for immunologic abortion. Clin. Appl. Immunol. Rev. 2 (2002) 187-199
51. Szekeres-Bartho J., Kilar F., Falkay G., Csernus V., Torok A., and Pacsa A.S. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis. Am. J. Reprod. Immunol. Microbiol. 9 (1985) 15-19
52. Szekeres-Bartho J., Faust Z., Varga P., Szereday L., and Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am. J. Reprod. Immunol. 35 4 (1996) 348-351
53. Tafuri A., Alferink J., Moller P., Hammerling G.J., and Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 270 5236 (1995) 630-633
54. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., and Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196 (2002) 447-457
55. Tezabwala B.U., Johnson P.M., and Rees R.C. Inhibition of pregnancy viability in mice following IL-2 administration. Immunology 67 1 (1989) 115-119
56. Widner B., Werner E.R., Schennach H., Wachter H., and Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43 12 (1997) 2424-2426
57. Widner B., Leblhuber F., Walli J., Tilz G.P., Demel U., and Fuchs D. Tryptophan degradation and immune activation in Alzheimer's disease. J. Neural Transm. 107 3 (2000) 343-353
58. Zenclussen A.C., Gentile T., Kortebani G., Mazzolli A., and Margni R. Asymmetric antibodies and pregnancy. Am. J. Reprod. Immunol. 45 5 (2001) 289-294
59. Zhou M., and Mellor A.L. Expanded cohorts of maternal CD8+ T-cells specific for paternal MHC class I accumulate during pregnancy. J. Reprod. Immunol. 40 1 (1998) 47-62